Scholars@Duke publication: The First Multi-Dose Trial of a Human Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH)

The First Multi-Dose Trial of a Human Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH)

Publication , Conference

Imel, EA; Zhang, X; Ruppe, MD; Weber, TJ; Klausner, M; Ito, T; Vergeire, M; Humphrey, J; Glorieux, FH; Portale, AA; Insogna, K; Peacoce, M ...

Published in: Endocrine Reviews

June 1, 2014

Endocrine Reviews

1945-7189

0163-769X

June 1, 2014

ENDOCRINE SOC

APA

Chicago

ICMJE

MLA

NLM

Imel, E. A., Zhang, X., Ruppe, M. D., Weber, T. J., Klausner, M., Ito, T., … Carpenter, T. (2014). The First Multi-Dose Trial of a Human Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH). In Endocrine Reviews (Vol. 35). ENDOCRINE SOC.

Imel, Erik Allen, Xiaoping Zhang, Mary Denise Ruppe, Thomas Joseph Weber, Mark Klausner, Takahiro Ito, Maria Vergeire, et al. “The First Multi-Dose Trial of a Human Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH).” In Endocrine Reviews, Vol. 35. ENDOCRINE SOC, 2014.

Imel EA, Zhang X, Ruppe MD, Weber TJ, Klausner M, Ito T, Vergeire M, Humphrey J, Glorieux FH, Portale AA, Insogna K, Peacoce M, Carpenter T. The First Multi-Dose Trial of a Human Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH). Endocrine Reviews. ENDOCRINE SOC; 2014.

Endocrine Reviews

1945-7189

0163-769X

June 1, 2014

ENDOCRINE SOC